Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients.

Lutgendorf SK, Weinrib AZ, Penedo F, Russell D, DeGeest K, Costanzo ES, Henderson PJ, Sephton SE, Rohleder N, Lucci JA 3rd, Cole S, Sood AK, Lubaroff DM.

J Clin Oncol. 2008 Oct 10;26(29):4820-7. doi: 10.1200/JCO.2007.14.1978. Epub 2008 Sep 8.

2.

Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: relationships with depression, fatigue, and disability.

Schrepf A, Clevenger L, Christensen D, DeGeest K, Bender D, Ahmed A, Goodheart MJ, Dahmoush L, Penedo F, Lucci JA 3rd, Ganjei-Azar P, Mendez L, Markon K, Lubaroff DM, Thaker PH, Slavich GM, Sood AK, Lutgendorf SK.

Brain Behav Immun. 2013 Mar;30 Suppl:S126-34. doi: 10.1016/j.bbi.2012.07.022. Epub 2012 Aug 5.

3.

Diurnal cortisol and survival in epithelial ovarian cancer.

Schrepf A, Thaker PH, Goodheart MJ, Bender D, Slavich GM, Dahmoush L, Penedo F, DeGeest K, Mendez L, Lubaroff DM, Cole SW, Sood AK, Lutgendorf SK.

Psychoneuroendocrinology. 2015 Mar;53:256-67. doi: 10.1016/j.psyneuen.2015.01.010. Epub 2015 Jan 20.

4.

Diurnal cortisol dysregulation, functional disability, and depression in women with ovarian cancer.

Weinrib AZ, Sephton SE, Degeest K, Penedo F, Bender D, Zimmerman B, Kirschbaum C, Sood AK, Lubaroff DM, Lutgendorf SK.

Cancer. 2010 Sep 15;116(18):4410-9. doi: 10.1002/cncr.25299.

5.

Sputum interleukin-6, tumor necrosis factor-α and Salivary cortisol as new biomarkers of depression in lung cancer patients.

Du YJ, Zhang HY, Li B, Wu X, Lv YB, Jin HL, Cao YX, Sun J, Luo QL, Gong WY, Liu BJ, Wu JF, Shi SX, Dong JC.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Dec 2;47:69-76. doi: 10.1016/j.pnpbp.2013.08.004. Epub 2013 Aug 19.

PMID:
23969030
6.

Association of pro-inflammatory cytokines, cortisol and depression in patients with chronic obstructive pulmonary disease.

Du YJ, Yang CJ, Li B, Wu X, Lv YB, Jin HL, Cao YX, Sun J, Luo QL, Gong WY, Zhang HY, Liu BJ, Wu JF, Dong JC.

Psychoneuroendocrinology. 2014 Aug;46:141-52. doi: 10.1016/j.psyneuen.2014.04.020. Epub 2014 May 2.

PMID:
24882166
7.

Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-α and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer.

Kolomeyevskaya N, Eng KH, Khan AN, Grzankowski KS, Singel KL, Moysich K, Segal BH.

Gynecol Oncol. 2015 Aug;138(2):352-7. doi: 10.1016/j.ygyno.2015.05.009. Epub 2015 May 20.

8.

Alterations in diurnal salivary cortisol rhythm in a population-based sample of cases with chronic fatigue syndrome.

Nater UM, Youngblood LS, Jones JF, Unger ER, Miller AH, Reeves WC, Heim C.

Psychosom Med. 2008 Apr;70(3):298-305. doi: 10.1097/PSY.0b013e3181651025. Epub 2008 Mar 31.

PMID:
18378875
9.

Associations of interleukin-6 with vegetative but not affective depressive symptoms in terminally ill cancer patients.

Inagaki M, Akechi T, Okuyama T, Sugawara Y, Kinoshita H, Shima Y, Terao K, Mitsunaga S, Ochiai A, Uchitomi Y.

Support Care Cancer. 2013 Aug;21(8):2097-106. doi: 10.1007/s00520-013-1767-x. Epub 2013 Feb 28.

PMID:
23446881
10.

Circadian disruption and biomarkers of tumor progression in breast cancer patients awaiting surgery.

Cash E, Sephton SE, Chagpar AB, Spiegel D, Rebholz WN, Zimmaro LA, Tillie JM, Dhabhar FS.

Brain Behav Immun. 2015 Aug;48:102-14. doi: 10.1016/j.bbi.2015.02.017. Epub 2015 Feb 26.

PMID:
25728235
11.

Salivary cortisol and depression in public sector employees: cross-sectional and short term follow-up findings.

Vammen MA, Mikkelsen S, Hansen ÅM, Grynderup MB, Andersen JH, Bonde JP, Buttenschøn HN, Kolstad HA, Kærgaard A, Kærlev L, Mors O, Rugulies R, Thomsen JF.

Psychoneuroendocrinology. 2014 Mar;41:63-74. doi: 10.1016/j.psyneuen.2013.12.006. Epub 2013 Dec 16.

PMID:
24495608
12.

Depressive symptoms and cortisol variability prior to surgery for suspected endometrial cancer.

Sannes TS, Jensen SE, Dodd SM, Kneipp SM, Garey Smith S, Patidar SM, Marsiske MM, Lutgendorf SM, Morgan LS, Pereira DB.

Psychoneuroendocrinology. 2013 Feb;38(2):241-9. doi: 10.1016/j.psyneuen.2012.06.001. Epub 2012 Jul 2.

13.

Biomarkers of depression in cancer patients.

Jehn CF, Kuehnhardt D, Bartholomae A, Pfeiffer S, Krebs M, Regierer AC, Schmid P, Possinger K, Flath BC.

Cancer. 2006 Dec 1;107(11):2723-9.

14.

BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.

Ninan PT, Shelton RC, Bao W, Guico-Pabia CJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:86-91. doi: 10.1016/j.pnpbp.2013.09.016. Epub 2013 Oct 2.

PMID:
24096053
15.

Plasma immune analytes in patients with epithelial ovarian cancer.

Block MS, Maurer MJ, Goergen K, Kalli KR, Erskine CL, Behrens MD, Oberg AL, Knutson KL.

Cytokine. 2015 May;73(1):108-13. doi: 10.1016/j.cyto.2015.01.035. Epub 2015 Mar 3.

16.

Effects of IL-6 and cortisol fluctuations in post-stroke depression.

Zhang XF, Zou W, Yang Y.

J Huazhong Univ Sci Technolog Med Sci. 2016 Oct;36(5):732-735. Epub 2016 Oct 18.

PMID:
27752894
17.

Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers.

Lane D, Matte I, Garde-Granger P, Laplante C, Carignan A, Rancourt C, Piché A.

BMC Cancer. 2015 Jul 1;15:492. doi: 10.1186/s12885-015-1511-7.

18.

Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer.

Plante M, Rubin SC, Wong GY, Federici MG, Finstad CL, Gastl GA.

Cancer. 1994 Apr 1;73(7):1882-8.

19.

High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer.

Gastl G, Plante M, Finstad CL, Wong GY, Federici MG, Bander NH, Rubin SC.

Br J Haematol. 1993 Mar;83(3):433-41.

PMID:
8485049
20.

Diurnal cortisol rhythm as a predictor of lung cancer survival.

Sephton SE, Lush E, Dedert EA, Floyd AR, Rebholz WN, Dhabhar FS, Spiegel D, Salmon P.

Brain Behav Immun. 2013 Mar;30 Suppl:S163-70. doi: 10.1016/j.bbi.2012.07.019. Epub 2012 Aug 3.

PMID:
22884416

Supplemental Content

Support Center